Pharmacovigilance System Transfer.
A practical two-part guide.
“Throwing good money after bad is never a good idea, yet all too often, pharma companies persevere with poor or inadequate PV information capture and reporting capabilities because the alternative – moving to a new provider – is seen as too great an upheaval and potentially too much risk.”
In this practical two-part guide, Cláudia Serafim, PV Manager & EU QPPV at Arriello, dispels the common myths around PV system transfer, sets out the benefits of making the change sooner rather than later, and provides a 13-part action plan to make the transition easy, and successful.
